Blood Clotting Tests: PT, INR, APTT, and D-Dimer

 

Blood Clotting Tests Explained: PT, INR, APTT, and D-Dimer

Blood coagulation — the ability of blood to clot — is one of the most precisely regulated processes in the human body. Too little clotting and you bleed dangerously. Too much and you form clots that block arteries and veins. The tests that measure this system — prothrombin time (PT), INR, activated partial thromboplastin time (APTT), and D-dimer — appear on blood test reports in a variety of clinical situations, and understanding what they measure can help patients make sense of their diagnoses and treatment.

The Coagulation Cascade

Blood clotting is not a simple process — it involves a cascade of proteins (clotting factors) that activate each other in sequence, amplifying a small initial signal into a robust clot. There are two main pathways: the extrinsic pathway (triggered by tissue damage, measured by PT/INR) and the intrinsic pathway (measured by APTT). They converge on a common pathway that produces fibrin — the structural scaffold of a clot.

Prothrombin Time (PT) and INR

What PT Measures

PT measures how long it takes blood to clot via the extrinsic and common pathways. It tests clotting factors I (fibrinogen), II (prothrombin), V, VII, and X. Normal PT is approximately 11–14 seconds, though this varies between labs. A prolonged PT means clotting is slower than normal.

INR — Standardising the Measurement

Different laboratories use different reagents to perform the PT test, producing different absolute results for the same blood sample. The International Normalised Ratio (INR) is a standardised calculation that corrects for these differences, allowing PT results to be compared across laboratories worldwide. Normal INR is approximately 0.8–1.2. INR is the clinically used value in practice.

What Causes a Prolonged PT/Elevated INR

• Liver disease: The liver produces most clotting factors. A rising INR in a patient with liver disease signals deteriorating synthetic function and is a serious prognostic marker.

• Warfarin therapy: Warfarin (used for stroke prevention in atrial fibrillation, treatment of blood clots) deliberately elevates INR. The target range depends on the indication — typically 2.0–3.0. Monitoring INR is essential for warfarin dose adjustment.

• Vitamin K deficiency: Vitamin K is essential for the synthesis of clotting factors II, VII, IX, and X. Deficiency (from malabsorption, antibiotic use, or poor diet) prolongs PT.

• Disseminated intravascular coagulation (DIC): A serious complication of severe sepsis, obstetric emergencies, or major trauma in which clotting factors are consumed throughout the body, leading simultaneously to bleeding and clotting.

APTT — Activated Partial Thromboplastin Time

APTT measures the intrinsic and common clotting pathway — testing factors VIII, IX, XI, XII, and the common pathway factors. Normal APTT is approximately 25–38 seconds.

Elevated APTT

• Haemophilia A (factor VIII deficiency) or haemophilia B (factor IX deficiency): X-linked bleeding disorders causing prolonged APTT with normal PT

• Heparin therapy: Unfractionated heparin acts on the intrinsic pathway; APTT is used to monitor its effect, with a target of 1.5–2.5 times normal

• Lupus anticoagulant: An autoantibody paradoxically associated with an increased thrombotic (clotting) risk despite prolonging APTT in vitro

• von Willebrand disease: The most common inherited bleeding disorder, which may prolong APTT

D-Dimer

D-dimer is a protein fragment released when a blood clot is broken down (fibrinolysis). A normal D-dimer result is highly useful for ruling out active clot-related conditions. An elevated D-dimer indicates that clot breakdown is occurring somewhere in the body — but it is not specific to any single cause.

Clinical Uses of D-Dimer

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

When someone presents with leg swelling, calf pain, or unexplained breathlessness, D-dimer is used as a negative predictor. If D-dimer is normal (in a patient with low clinical probability of DVT/PE), the diagnosis can be effectively excluded without further imaging. If elevated, it mandates Doppler ultrasound (for DVT) or CT pulmonary angiography (for PE) to confirm or exclude the diagnosis. A positive D-dimer alone is not diagnostic — it rises in many conditions including pregnancy, infection, inflammation, cancer, recent surgery, and simply with age.

COVID-19 and D-Dimer

One of the recognised features of severe COVID-19 is a markedly elevated D-dimer, reflecting widespread microvascular thrombosis. Elevated D-dimer in COVID-19 patients is associated with significantly worse outcomes and has been used as a marker for anticoagulation decisions.

DIC

In disseminated intravascular coagulation, D-dimer is typically dramatically elevated alongside prolonged PT and APTT, low platelets, and low fibrinogen — reflecting simultaneous widespread clotting and fibrinolysis throughout the body.

�� If your doctor has ordered coagulation tests, it is because they need to understand your blood's clotting function. Never stop anticoagulation medication without medical advice — doing so can be immediately life-threatening.

�� Get instant interpretation of your lab results — visit https://VincentAkwas.github.io/lablens — free, detailed clinical commentary for every value.